Song Ruixuan, Executive Chairman of the Chinese Pharmaceutical Promotion Association, met with counsellors from the Dutch Embassy in Beijing

On the afternoon of January 5, 2021, Song Ruixuan, Executive Director of the China Pharmaceutical Innovation Promotion Association ("China Pharmaceutical Promotion Association"), met with Peter A. Bootsma, outgoing Counsellor for Health, Welfare and Sports of the Embassy of the Kingdom of the Netherlands in China (the "Embassy of the Netherlands"), and Mr. Nico Settechikatte, the new Counsellor.
the two sides held in-depth exchanges on strengthening exchanges between the biopharmaceutical industries of China and the Netherlands and promoting the establishment of a mutual recognition system for the new crown vaccine between China and the Netherlands.
president first welcomed the two visiting counsellors and expressed his heartfelt wishes to the outgoing Mr. Peter.
President Song spoke highly of the achievements of the cooperation between the Chinese Pharmaceutical Promotion Association and the Dutch Embassy during Mr. Peter's term in office, and looked forward to the two sides continuing to deepen cooperation and jointly promote the exchange and development of the pharmaceutical industry between China and the Netherlands.
Said that the current world political and economic situation is facing great changes and that the successful signing of the China-EU Investment Agreement is of far-reaching significance for deepening cooperation between China and the EU.
China and the Netherlands should strengthen exchanges and cooperation in the field of pharmaceutical innovation and investment, create a platform for exchanges and dialogue between pharmaceutical industry experts and entrepreneurs of the two countries, and give full play to the outstanding advantages of the Netherlands in the field of drug research and development and health care, and contribute to the development of the global pharmaceutical industry by taking advantage of the location advantages of the relocation of the European Drug Administration (EMA) to Amsterdam.
In view of the current situation of the global new crown epidemic and vaccine research and development, President Song believes that breaking the international travel restrictions and regional isolation caused by the outbreak requires the establishment of an international mutual recognition system for vaccine effectiveness and strict preventive measures, and the World Health Organization (WHO) should play a leading role in this process.
Peter expressed his high approval and appreciation for President Song's views and said that the cooperation model and results of the Dutch Embassy and the Chinese Pharmaceutical Promotion Association were outstanding examples, and that the Dutch Embassy would continue to recommend Dutch medicine experts and high-quality pharmaceutical innovation enterprises to participate in the relevant international activities of the Chinese Pharmaceutical Association.
The Netherlands Drug Evaluation Commission (CBG) and China's State Drug Administration have maintained close communication and cooperation, EMA relocation to Amsterdam, the Netherlands will be Europe and the rest of the world's pharmaceutical industry and regulatory liaison hub, in pharmaceutical research and development, product recognition mechanism, etc. play a more important role.
Nico said he will continue to maintain good cooperative relations with the China Pharmaceutical Promotion Association and will actively promote efforts to deepen non-governmental exchanges and cooperation between the chinese and Dutch pharmaceutical industries during his term in office.
the establishment of a new crown vaccine mutual recognition system will also help accelerate the restoration of the international economic order, reduce barriers to international research and development of medicine, and help the global community to overcome the epidemic.
the meeting deepened cooperation and exchanges between China and the Netherlands in the fields of pharmaceutical innovation and research and development, and laid a solid foundation for promoting deeper cooperation between the pharmaceutical industry of the two countries in the future.
The meeting was attended by Liang Yan, Life Sciences and Medical Officer of the Embassy of the Kingdom of the Netherlands in China, Lu Xiaoxuan, Deputy Secretary-General of the Chinese Drug Promotion Association, Yu Xinxin, Deputy Director of the International Department, and Li Gen, Project Director.
meeting site The new Health, Welfare and Sports Counsellor at the Embassy of the Kingdom of the Netherlands in China, Nico Schiettekatte (first from left) And Song Ruixuan (centre), Executive Director of the Chinese Association for the Promotion of Pharmaceutical Innovation, the outgoing Counsellor for Health, Welfare and Sports of the Kingdom of the Netherlands embassy in China, Peter A. Bootsma (first from right)